Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K. S. Polonsky
Response Letter to Comment On: Villareal Et Al. (2009) TCF7L2 Variant Rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action. Diabetes; 59:479-485
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Insulin Release in Impaired Glucose Tolerance: Oral Minimal Model Predicts Normal Sensitivity to Glucose but Defective Response Times
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
TCF7L2 Variant Rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Related publications
Effect of a Long-Term Behavioural Weight Loss Intervention on Nephropathy in Overweight or Obese Adults With Type 2 Diabetes: A Secondary Analysis of the Look AHEAD Randomised Clinical Trial
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
Shrinkage of Pituitary Adenomas With Pasireotide
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
Family Matters in Diabetes Care
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
Potential Antitumour Activity of Pasireotide on Pituitary Tumours in Acromegaly
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
Preoperative Prediction of Type 2 Diabetes Remission After Roux-En-Y Gastric Bypass Surgery: A Retrospective Cohort Study
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
The Sex-Specific Association Between BMI and Coronary Heart Disease: A Systematic Review and Meta-Analysis of 95 Cohorts With 1·2 Million Participants
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
An Active Life Is a Sweet Life
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
Within-Trial Cost and 1-Year Cost-Effectiveness of the DiRECT/Counterweight-Plus Weight-Management Programme to Achieve Remission of Type 2 Diabetes
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
Meta-Analysis of Artificial Pancreas Trials: Methodological Considerations
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
Health-Care Costs Over 15 Years After Bariatric Surgery for Patients With Different Baseline Glucose Status: Results From the Swedish Obese Subjects Study
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
